In contrast, within tumor tissues, T cells expressing CD69, including the CD69+CD103+CD8+ population, were associated with an increased recurrence risk, whereas increased frequencies of CD69−CD4+ and CD69−CD8+ T cells were associated with better outcomes (Table 2). The gene discussed is CD69; the disease is neoplasm.